Stay updated with breaking news from Controlled Medication. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
DEA and SAMHSA issued a temporary rule extending telemedicine flexibilities adopted during the COVID-19 public health emergency. Current flexibilities that allow providers to prescribe certain controlled substances via telemedicine will continue through November 11, 2023.
IAP members are appointed by mutual agreement of HISA and HIWU for four-year terms and serve as independent contractors to both entities.
The Horseracing Integrity and Safety Authority released the following Q & A conducted with Craig Bandoroff of Denali Stud regarding questions that he submitted, as a supporter of HISA, about the Anti-Doping and Medication Control Program.
The anticipated March 27 implementation of HISA's Anti-Doping and Medication Control (ADMC) Program is approaching
The Horseracing Integrity and Safety Authority (HISA) and Horseracing Integrity & Welfare Unit (HIWU) are accepting inquiries from individuals interested in serving on the Internal Adjudication Panel (IAP) established by HISA’s Anti-Doping and Medication Control (ADMC) Program, which goes into effect Jan. 1, 2023.